Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1230PDF: 609HTML: 6806 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3706PDF: 909HTML: 6728 -
-
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3616PDF: 1522HTML: 4441CoverLetter: 190Figure1: 204 -
-
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1662PDF: 601HTML: 237 -
-
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1331PDF: 608HTML: 3189 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4846PDF: 1334HTML: 1920Untitled: 188Untitled: 182 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3410PDF: 1501HTML: 4017 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1419HTML: 482PDF: 844 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3804PDF: 1607HTML: 531Figures . Eliassian: 230 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4425PDF: 935HTML: 1333Table1: 190 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2522PDF: 1331HTML: 1801CoverLetter: 186 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3613PDF: 2546HTML: 1510 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1813PDF: 1187HTML: 258 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4207PDF: 1962HTML: 5341Table 1: 214 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2212PDF: 1622HTML: 319 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2333PDF: 1345HTML: 17103Bassan Fig.1: 152Bassan Fig.2: 164Bassan Fig.4: 144Fig.3: 209 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2153PDF: 1558HTML: 525 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1146PDF: 553HTML: 1700Figures: 176Fifures Sanz: 182tables Sanz: 185Untitled: 184 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1717PDF: 831HTML: 940cover letter: 276 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2421PDF: 1016HTML: 1655Fig 1: 195Tab I: 221Cover Letter: 213 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1508PDF: 636HTML: 272 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2340PDF: 1192HTML: 656 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4872PDF: 2886HTML: 2320







